rewirebio.iobenchmarks
Dataset

Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)

Clinical WES of 180 unrelated patients; 44 also had chromosomal microarray, of whom 39 contributed 98 high-quality reference CNVs spanning 2,788 exons.

Evaluation results

8 evaluations · 48 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: cn.MOPS v1.14.1, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2280 False negatives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cn.MOPS (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FN', column 'cn.MOPS' / 'Post-filter'
Configuration: cn.MOPS v1.14.1, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2630 False positives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cn.MOPS (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FP', column 'cn.MOPS' / 'Post-filter'
Configuration: cn.MOPS v1.14.1, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.144 Precision (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cn.MOPS (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'PPV', column 'cn.MOPS' / 'Post-filter'
Configuration: cn.MOPS v1.14.1, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2720 Count (exon level; reference CMA CNV exons in the evaluated set)
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cn.MOPS (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Reference Truth set', column 'cn.MOPS' / 'Post-filter'
Configuration: cn.MOPS v1.14.1, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.162 Recall (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cn.MOPS (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Sensitivity', column 'cn.MOPS' / 'Post-filter'
Configuration: cn.MOPS v1.14.1, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
441 True positives (exon level)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cn.MOPS (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'TP', column 'cn.MOPS' / 'Post-filter'
Configuration: CNVkit v0.9.7, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
866 False negatives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CNVkit (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FN', column 'CNVkit' / 'Post-filter'
Configuration: CNVkit v0.9.7, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
6580 False positives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CNVkit (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FP', column 'CNVkit' / 'Post-filter'
Configuration: CNVkit v0.9.7, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.219 Precision (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CNVkit (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'PPV', column 'CNVkit' / 'Post-filter'
Configuration: CNVkit v0.9.7, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2710 Count (exon level; reference CMA CNV exons in the evaluated set)
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CNVkit (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Reference Truth set', column 'CNVkit' / 'Post-filter'
Configuration: CNVkit v0.9.7, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.68 Recall (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CNVkit (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Sensitivity', column 'CNVkit' / 'Post-filter'
Configuration: CNVkit v0.9.7, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
1840 True positives (exon level)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CNVkit (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'TP', column 'CNVkit' / 'Post-filter'
Configuration: CoNIFER v0.2.2, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
620 False negatives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CoNIFER (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FN', column 'CoNIFER' / 'Post-filter'
Configuration: CoNIFER v0.2.2, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
6290 False positives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CoNIFER (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FP', column 'CoNIFER' / 'Post-filter'
Configuration: CoNIFER v0.2.2, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.25 Precision (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CoNIFER (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'PPV', column 'CoNIFER' / 'Post-filter'
Configuration: CoNIFER v0.2.2, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2710 Count (exon level; reference CMA CNV exons in the evaluated set)
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CoNIFER (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Reference Truth set', column 'CoNIFER' / 'Post-filter'
Configuration: CoNIFER v0.2.2, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.771 Recall (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CoNIFER (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Sensitivity', column 'CoNIFER' / 'Post-filter'
Configuration: CoNIFER v0.2.2, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2090 True positives (exon level)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CoNIFER (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'TP', column 'CoNIFER' / 'Post-filter'
Configuration: ExomeDepth v1.1.15, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
207 False negatives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ExomeDepth (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FN', column 'ExomeDepth' / 'Post-filter'
Configuration: ExomeDepth v1.1.15, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
16,797 False positives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ExomeDepth (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FP', column 'ExomeDepth' / 'Post-filter'
Configuration: ExomeDepth v1.1.15, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.102 Precision (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ExomeDepth (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'PPV', column 'ExomeDepth' / 'Post-filter'
Configuration: ExomeDepth v1.1.15, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2120 Count (exon level; reference CMA CNV exons in the evaluated set)
count · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ExomeDepth (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Reference Truth set', column 'ExomeDepth' / 'Post-filter'
Configuration: ExomeDepth v1.1.15, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
0.903 Recall (exon level)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ExomeDepth (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'Sensitivity', column 'ExomeDepth' / 'Post-filter'
Configuration: ExomeDepth v1.1.15, post-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, after removing tool-specific problematic regions (Hwang et al. Table 4, post-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
1920 True positives (exon level)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ExomeDepth (post-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-post-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'TP', column 'ExomeDepth' / 'Post-filter'
Configuration: cn.MOPS v1.14.1, pre-filter (Hwang et al. 2026)Protocol: Exon-level CNV detection in clinical exomes against CMA truth, default calls (Hwang et al. Table 4, pre-filter)
Dataset: Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
2310 False negatives (exon level)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

cn.MOPS (pre-filter) on 39 clinical exomes against CMA truth

cnv-20261011-hwang2026-protocol-pre-filter

Aggregation: Not reported

Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026) · Table 4, row 'FN', column 'cn.MOPS' / 'Pre-filter'

Source checking is not independent reproduction. Release 2026-11-02-a7f03c9e55a5.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-02-a7f03c9e55a5 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

7 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-02-a7f03c9e55a5
Property and statementOriginal source and locationReview and provenance
Assay
Agilent SureSelect Human All Exon v6, Illumina NovaSeq 6000 2 x 150 bp, mean on-target depth 110x; BWA-MEM v0.7.17 to GRCh37; CMA on CytoScan Dx and 750K arrays analysed with ChAS
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
39 CMA-positive individuals; 98 reference CNVs (39 deletions, 59 duplications; 5.03 kb to 6.91 Mb) covering 2,058 deleted and 730 duplicated exons; the other 141 exomes were used only to define problematic regions
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
Methods 2.1 and 2.2; Table 1; Results 3.1
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Split
No split
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
As published (raw data not shared in the article)
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Clinical WES of 180 unrelated patients; 44 also had chromosomal microarray, of whom 39 contributed 98 high-quality reference CNVs spanning 2,788 exons.
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
Korea University clinical exomes with CMA reference CNVs (Hwang et al. 2026)
Context-only references
Improving CNV Detection Performance Except for Software-Specific Problematic Regions (Hwang et al., Genes 2026)

Original source ↗

Methods 2.1 and 2.2; Table 1; Results 3.1

Version: Genes 17(1):105, published 2026-01-19; PMC12841491 full-text XML
Retrieved: 2026-10-11T21:36:59Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: ff82a186d0adcf319b603a1100427ec0f6ed95becf040b512d0aef5e515bdc5d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-02-a7f03c9e55a5 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: cnv-20261011-hwang2026-data-korea-wes-cma-39

areas
dna-genomes
contexts
clinical_research
version
As published (raw data not shared in the article)
assay
Agilent SureSelect Human All Exon v6, Illumina NovaSeq 6000 2 x 150 bp, mean on-target depth 110x; BWA-MEM v0.7.17 to GRCh37; CMA on CytoScan Dx and 750K arrays analysed with ChAS
population
39 CMA-positive individuals; 98 reference CNVs (39 deletions, 59 duplications; 5.03 kb to 6.91 Mb) covering 2,058 deleted and 730 duplicated exons; the other 141 exomes were used only to define problematic regions
split
No split
source locator
Methods 2.1 and 2.2; Table 1; Results 3.1
Related records

Suggest a correction